Abstract
Development of a targeted polymeric gene delivery system is essential for reducing the non-specific uptake and toxicity of the gene carriers. In this study, we have tested the specificity of the cell penetrating peptide (DS 4-3), screened by phage display technique, towards metastatic breast cancer cells. This peptide has shown specificity towards metastatic breast cancer cells, which was confirmed through endocytosis inhibition study. Furthermore, the DS 4-3 peptide was conjugated to bPEI, to deliver the therapeutic miR-145. Tumor suppressor miR-145 inhibited tumor cell growth, and significantly suppressed cell invasion. The DS 4-3 peptide conjugated branched PEI (DSbPEI)/pLuc nanoparticles showed increased transfection in malignant murine breast cancer cells at the neutral surface charge (N/P molar ratio of 3), compared to scramble peptide conjugated bPEI/pLuc nanoparticles, without causing any cytotoxicity. This specific increase in transfection with DS-bPEI/pLuc nanoparticles was not found in the cancer cells that originated from different tissue, such as HeLa cervical cancer cells, or in the normal cells, such as NIH-3T3 murine fibroblast cells. Thus, the specific transfection of miR-145 in metastatic breast cancer cells mediated by DS-bPEI resulted in enhanced reduction in proliferation.
Similar content being viewed by others
References
G. Romano, C. Pacilio, and A. Giordano, Stem Cells, 17, 191 (1999).
C. T. Leong, C. K. Ong, S. K. Tay, and H. Huynh, Oncogene, 26, 870 (2007).
L. Huang, Q. Ao, Q. Zhang, X. Yang, H. Xing, F. Li, G. Chen, J. Zhou, S. Wang, G. Xu, L. Meng, Y. Lu, and D. Ma, J. Cancer Res. Clin. Oncol., 136, 447 (2010).
J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John, V. Kesavan, G. Lavine, R. K. Pandey, T. Racie, K. G. Rajeev, I. Rohl, I. Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan, and H. P. Vornlocher, Nature, 432, 173 (2004).
A. L. Kasinski and F. J. Slack, Cancer Res., 72, 5576 (2012).
J. B. Weidhaas, I. Babar, S. M. Nallur, P. Trang, S. Roush, M. Boehm, E. Gillespie, and F. J. Slack, Cancer Res., 67, 11111 (2007).
X. Ye, Z. Liu, M. G. Hemida, and D. Yang, PLoS One, 6, e21215 (2011).
E. Ylösmäki, S. Lavilla-Alonso, S. Jäämaa, M. Vähä-Koskela, T. af Hällström, A. Hemminki, J. Arola, H. Mäkisalo, and K. Saksela, PLoS One, 8, e54506 (2013).
H. Zhang, J. Pu, T. Qi, M. Qi, C. Yang, S. Li, K. Huang, L. Zheng, and Q. Tong, Oncogene, doi:10.1038/onc.2012.574 (2012).
M. Sachdeva and Y. Y. Mo, Cancer Res., 70, 378 (2010).
P. Dynoodt, R. Speeckaert, O. De Wever, I. Chevolet, L. Brochez, J. Lambert, and M. Van Gele, Int. J. Oncol., 42, 1443 (2013).
X. Wu, Z. Li, M. Yao, H. Wang, S. Qu, X. Chen, J. Li, Y. Sun, Y. Xu, and J. Gu, Acta Biochim. Biophys. Sin., 40, 217 (2008).
C. F. LeMaistre, C. Meneghetti, L. Howes, and C. K. Osborne, Breast Cancer Res. Treat., 32, 97 (1994).
D. G. Gilyazova, A. A. Rosenkranz, P. V. Gulak, V. G. Lunin, O. V. Sergienko, Y. V. Khramtsov, K. N. Timofeyev, M. A. Grin, A. F. Mironov, A. B. Rubin, G. P. Georgiev, and A. S. Sobolev, Cancer Res., 66, 10534 (2006).
S. Gerbal-Chaloin, C. Gondeau, G. Aldrian-Herrada, F. Heitz, C. Gauthier-Rouviere, and G. Divita, Biol. Cell, 99, 223 (2007).
C. Buerger and B. Groner, J. Cancer Res. Clin. Oncol., 129, 669 (2003).
L. E. Yandek, A. Pokorny, A. Floren, K. Knoelke, U. Langel, and P. F. Almeida, Biophys. J., 92, 2434 (2007).
J. Nguyen, X. Xie, M. Neu, R. Dumitrascu, R. Reul, J. Sitterberg, U. Bakowsky, R. Schermuly, L. Fink, T. Schmehl, T. Gessler, W. Seeger, and T. Kissel, J. Gene Med., 10, 1236 (2008).
F. Salomone, F. Cardarelli, M. Di Luca, C. Boccardi, R. Nifosi, G. Bardi, L. Di Bari, M. Serresi, and F. Beltram, J. Control. Release, 163, 293 (2012).
S. L. Fang, T. C. Fan, H. W. Fu, C. J. Chen, C. S. Hwang, T. J. Hung, L. Y. Lin, and M. D. Chang, PLoS One, 8, e57318 (2013).
G. Ter-Avetisyan, G. Tunnemann, D. Nowak, M. Nitschke, A. Herrmann, M. Drab, and M. C. Cardoso, J. Biol. Chem., 284, 3370 (2009).
P. Saalik, A. Niinep, J. Pae, M. Hansen, D. Lubenets, U. Langel, and M. Pooga, J. Control. Release, 153, 117 (2011).
T. Takeuchi, M. Kosuge, A. Tadokoro, Y. Sugiura, M. Nishi, M. Kawata, N. Sakai, S. Matile, and S. Futaki, ACS Chem. Biol., 1, 299 (2006).
M. Fotin-Mleczek, S. Welte, O. Mader, F. Duchardt, R. Fischer, H. Hufnagel, P. Scheurich, and R. Brock, J. Cell Sci., 118, 3339 (2005).
M. Whitney, J. L. Crisp, E. S. Olson, T. A. Aguilera, L. A. Gross, L. G. Ellies, and R. Y. Tsien, J. Biol. Chem., 285, 22532 (2010).
A. Chauhan, A. Tikoo, A. K. Kapur, and M. Singh, J. Control. Release, 117, 148 (2007).
Y. Lee, H. Y. Nam, J. Kim, M. Lee, J. W Yockman, S. K. Shin, and S. W. Kim, Mol. Ther., 20, 1360 (2012).
H. Bachtarzi, M. Stevenson, V. Subr, K. Ulbrich, L. W. Seymour, and K. D. Fisher, J. Control. Release, 150, 196 (2011).
K. Anwer, B. G. Rhee, and S. K. Mendiratta, Crit. Rev. Ther. Drug Carrier Syst., 20, 249 (2003).
R. Namgung, K. Singha, M. K. Yu, S. Jon, Y. S. Kim, Y. Ahn, I. K. Park, and W. J. Kim, Biomaterials, 31, 4204 (2010).
S. M. Kwon, H. Y. Nam, T. Nam, K. Park, S. Lee, K. Kim, I. C. Kwon, J. Kim, D. Kang, J. H. Park, and S. Y. Jeong, J. Control. Release, 128, 89 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, H.J., Namgung, R., Kim, W.J. et al. Targeted delivery of microRNA-145 to metastatic breast cancer by peptide conjugated branched PEI gene carrier. Macromol. Res. 21, 1201–1209 (2013). https://doi.org/10.1007/s13233-013-1161-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13233-013-1161-z